Alan Hulme
Chairman
life science
Oncopeptides AB (ONCO.ST)
Sweden
Biography
Alan Hulme has been Chairman of the Board of Directors of Oncopeptides AB since April 2010. In addition, Alan works across Europe with other development stage client companies in the life sciences sector, providing corporate development consultancy services through TechGen International Ltd, London. Previous positions Alan has held have include various senior executive/officer level positions in a number of NYSE and NASDAQ listed life sciences companies in the US as well as two European companies. Alan has also co-founded a venture backed start up. Alan has been located for extensive periods in Asia, the US (East Coast, West Coast and mid-West) and with secondments to Europe, including the UK, Germany, France and Norway. He is Director of Oncopeptides Incentive AB, Techgen Corporate Development Ltd and Techgen International Ltd.
Research Interest
business and administration
